The market opened in the green on February 6, 2020, overall volumes in futures & options currently stand at 2.74 crore contracts with a turnover of Rs. 19,60,373.95 crore.

Vaishali Pharma Limited has received a registration for three products including VMOX CV-1200, VMOX CV-600, and CYBUFIN-1,500 in Myanmar market. These products have a good demand in the local market of Myanmar.

The market opened in the green on February 6, 2020. The previous trading session witnessed the Sensex going up by 353.28 points to end at 41,142.66 and the Nifty was up by 109.50 points to close at 12,089.15. 

Pharma major-Lupin Limited announced, after the trading hours on Wednesday, that it has received approval from the United States Food and Drug Administration (USFDA) for its Leflunomide tablets USP, 10 mg and 20 mg. The drug is used for treating adults with active rheumatoid arthritis.

The market opened in the green on February 6, 2020. The previous trading session witnessed the Sensex going up by 353.28 points to end at 41,142.66 and the Nifty was up by 109.50 points to close at 12,089.15. 

A V-shaped recovery, which we have witnessed from the lower levels, is nearing a crucial mark and some consolidation at the current levels is important before the next leap. At the same, time it is important for the bulls to hold 11,920 mark. Stocks in news: ITI, Lupin, Sagar Cement.

In the last session, the bulls scored a hat-trick of gains and reclaimed the 12,000 mark on Nifty. On Thursday, the pitch is firm for the bulls to bat on and extend its upmove for the fourth straight day as global cues are cheerful. However, SGX Nifty in the early trend is indicating a cautious start ahead of the RBI’s Monetary Policy Committee’s policy outcome.

In the season of tax saving, avoid some of the common mistakes that might hurt you in the future. Read on to find out more about these mistakes.

The following stocks will be in focus during Thursday’s trading session in the light of their result announcements: Aarti Drugs, Aditya Birla Fashion & Retail, Bata India, Eicher Motors and Lupin.

JB Chemicals & Pharmaceuticals' board has approved the purchase of entire trademarks portfolio of Unique Pharmaceutical Laboratories Ltd (UPLL) at onetime consideration of Rs 8 crore. The transaction would be completed before the end of this year.